Structures and Properties of Known and Postulated Interstellar Cations.

Autor: Tinacci, Lorenzo, Pantaleone, Stefano, Maranzana, Andrea, Balucani, Nadia, Ceccarelli, Cecilia, Ugliengo, Piero

Publikováno v: Astrophysical Journal Supplement Series; Oct2021, Vol. 256 Issue 2, p1-10, 10p

Chile: para um desenvolvimento inclusivo.

Autor: Infante, B. Ricardo infanter@mi.cl, Sunkel, Osvaldo osvaldo.sunkel@cepal.org

Publikováno v: Revista de la CEPAL. abr2010, Issue 100, p143-162. 20p. 1 Diagram, 10 Charts.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Autor: Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk., Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; The Jenner Institute, University of Oxford, Oxford, UK., Babbage G; The Jenner Institute, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK., Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK., Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK., Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK., Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Hou MM; The Jenner Institute, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK., Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK., Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Makinson R; The Jenner Institute, University of Oxford, Oxford, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK., Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK., Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK., Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA., Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.

Publikováno v: Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Autor: Barrett JR; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbride C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Halkerston R; Public Health England, Salisbury, UK., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Daniel.Jenkin@ndm.ox.ac.uk., Stockdale L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Verheul MK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bellamy D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Berrie E; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Carroll MW; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cavell B; Public Health England, Salisbury, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Edwards N; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gorringe A; Public Health England, Salisbury, UK., Hallis B; Public Health England, Salisbury, UK., Kerridge S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lawrie AM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Madhavan M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Makinson R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Mellors J; Public Health England, Salisbury, UK., Minassian A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Tarrant R; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Taylor S; Public Health England, Salisbury, UK., Thomas KM; Public Health England, Salisbury, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Watson MEE; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Green CM; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Hill AVS; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.Pollard@paediatrics.ox.ac.uk.

Publikováno v: Nature medicine [Nat Med] 2021 Jun; Vol. 27 (6), pp. 1113.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Autor: Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Costa Clemens SA; Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Baillie VL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Barnabas SL; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa., Bhorat QE; Soweto Clinical Trials Centre, Soweto, South Africa., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Briner C; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Cutland CL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Dheda K; Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman A; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Finn A; School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK., Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK., Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK., Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK., Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hill C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK., Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Joe CCD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Koen A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Kwatra G; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK., Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK., Lillie PJ; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Marshall RP; AstraZeneca BioPharmaceuticals, Cambridge, UK., Mendes AVA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil., Milan EP; Universidade Federal do Rio Grande do Norte, Natal, Brazil., Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., McGregor A; London Northwest University Healthcare, Harrow, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Nana A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Padayachee SD; Setshaba Research Centre, Pretoria, South Africa., Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pittella A; Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pollock KM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ritchie AJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil., Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Thomson EC; MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK., Török ME; Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Toshner M; Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK., Turner DPJ; University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK., Vekemans J; AstraZeneca BioPharmaceuticals, Cambridge, UK., Villafana TL; AstraZeneca BioPharmaceuticals, Cambridge, UK., White T; AstraZeneca BioPharmaceuticals, Cambridge, UK., Williams CJ; Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales., Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.

Publikováno v: Lancet (London, England) [Lancet] 2021 Mar 06; Vol. 397 (10277), pp. 881-891. Date of Electronic Publication: 2021 Feb 19.